Form 4: Guardant Health Director Exercises Stock Options
SEC Form 4 Filing
Meghan V. Joyce, a director at Guardant Health, Inc., executed stock options and disposed of restricted stock units on September 4, 2024.
Summary
- On September 4, 2024, Meghan V. Joyce, a director of Guardant Health, Inc., engaged in transactions involving the company's stock.
- Joyce exercised stock options, acquiring 67 shares of common stock at a price of $0.
- Concurrently, Joyce disposed of 67 restricted stock units.
- Following these transactions, Joyce directly owns 10,412 shares of Guardant Health common stock and 730 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral reporting of a transaction. It doesn't inherently indicate positive or negative sentiment about the company.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC when a company insider, such as a director, engages in transactions involving the company's securities. It provides transparency to the market regarding insider activity.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it involves a small number of shares.
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| August 4, 2022 | Initial vesting date for 25% of the restricted stock units. |
| September 4, 2024 | Date of transaction: stock option exercise and disposal of restricted stock units. |
| September 5, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.